$BNTX $PFE $NTGN #BioNTech and #Pfizer announce regulatory approval from #German authority Paul-Ehrlich-Institut to commence first clinical trial of #COVID-19 vaccine candidates - 22.04.20 - News - https://t.co/v7GTQVIhdU https://t.co/mBRIslEj5O